Financing channel feed – Endpoints News

Financing channel feed

Lilly-partnered Fauna Bio plans $40M Series A to get into heart failure

2 months ago

Montara Therapeutics adds $20M to seed fundraise for neurology pipeline

2 months ago

Insilico nabs $110M Series E for AI drug discovery after stalling Hong Kong IPO plans

2 months ago

Longtime biotech investor Frazier Life Sciences is raising its latest venture fund

2 months ago

Lilly, Pfizer invest in UK startup's seed round for neurodegeneration protein degraders

2 months ago

Sofinnova Partners raises €1.2B to back another 50 to 60 life sciences startups

2 months ago

ADCs from a decade-old Singapore biotech find new life with $187M

2 months ago

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

3 months ago

Eikon Therapeutics raises $351M Series D as lead drug starts Phase 3

3 months ago

En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse

3 months ago

Where the money is: The top 100 venture investors in biotech

3 months ago

Alcon tried to sink Aurion's IPO in 'Valentine's Day massacre,' new lawsuits say

3 months ago

23andMe's CEO submits bid to take company private for $74.7M

3 months ago

Nvidia-backed Achira debuts, blending AI and physics to model molecules

3 months ago

Paris startup collects €27M in Series B to advance overactive bladder treatment

3 months ago

Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion

3 months ago

Exclusive: Atomwise, a once high-flying AI startup, taps biotech vet as CEO to lead pared-down company

3 months ago

Pain biotech Latigo eyes up to $150M raise following Vertex's landmark FDA nod

3 months ago

BioNTech vets raise $90M Series A for bispecific I&I startup

3 months ago

Hunger-suppressing biotech Aardvark raises $94M in IPO

3 months ago

After helping build AlphaFold, a 34-year-old first-time CEO launches his own AI biotech with $50M

3 months ago

High medical costs have eaten away at CVS Health's earnings all year. There’s no quick fix

3 months ago

After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker

3 months ago

Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity

3 months ago

First page Previous page 1 2 345 6 7 Next page Last page